Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 Listed Suppliers

1 API Suppliers
1 Listed Suppliers

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 78214-33-2, 20(s)-ginsenoside rh2, (20s)-ginsenoside rh2, 20(s)-ginsenoside, Ginsenoside-rh2, Chebi:77147

Molecular Formula

C₃₆H₆₂O₈

Molecular Weight

622.9 g/mol

InChI Key

CKUVNOCSBYYHIS-IRFFNABBSA-N

FDA UNII

0JU44A5KWG

(20S)-ginsenoside rh2 is a natural product found in Panax ginseng and Panax notoginseng with data available.

1 2D Structure

Ginsenoside Rh2

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

2.1.2 InChI

InChI=1S/C36H62O8/c1-20(2)10-9-14-36(8,42)21-11-16-35(7)27(21)22(38)18-25-33(5)15-13-26(32(3,4)24(33)12-17-34(25,35)6)44-31-30(41)29(40)28(39)23(19-37)43-31/h10,21-31,37-42H,9,11-19H2,1-8H3/t21-,22+,23+,24-,25+,26-,27-,28+,29-,30+,31-,33-,34+,35+,36-/m0/s1

2.1.3 InChI Key

CKUVNOCSBYYHIS-IRFFNABBSA-N

2.1.4 Canonical SMILES

CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)O)C

2.1.5 Isomeric SMILES

CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)C)O)C)O)C

2.2 Other Identifiers

2.2.1 UNII

0JU44A5KWG

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Ginsenoside-rh2

2.3.2 Depositor-Supplied Synonyms

1. 78214-33-2

2. 20(s)-ginsenoside Rh2

3. (20s)-ginsenoside Rh2

4. 20(s)-ginsenoside

5. Ginsenoside-rh2

6. Chebi:77147

7. 20s-ginsenoside Rh2

8. 0ju44a5kwg

9. (2r,3r,4s,5s,6r)-2-[[(3s,5r,8r,9r,10r,12r,13r,14r,17s)-12-hydroxy-17-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

10. (20r)-ginsenoside Rh2

11. 20(s)-rh2

12. (3beta,12beta)-12,20-dihydroxydammar-24-en-3-yl Beta-d-glucopyranoside

13. (20r)ginsenoside Rh2

14. Ginsenosiderh2

15. 112246-15-8

16. (s)ginsenoside-rh2

17. 20s-ginsenosiderh2

18. Unii-0ju44a5kwg

19. Ginsenoside Rh2(s)

20. 20(s)- Ginsenoside Rh2

21. Ginsenoside 20-rh2

22. Chembl1783834

23. Dtxsid70999457

24. 67400-17-3

25. Hy-n0605

26. Bdbm50023457

27. Ginsenoside Rh2, Analytical Standard

28. Mfcd00800712

29. S9023

30. S9036

31. Zinc72129809

32. Akos037514675

33. Ccg-270259

34. Ccg-270261

35. Cs-3835

36. Ac-33940

37. Ginsenoside Rh2; 20(s)-ginsenoside Rh2

38. C22128

39. 20s-protopanaxdiol-3-o-beta-d- Glucopyranoside

40. 214g332

41. Q-100827

42. Q27146703

43. 3-o-.beta.-d-glucopyranosyl-20(s)-protopanaxadiol

44. 3beta-(beta-d-glucopyranosyloxy)dammar-24-ene-3beta,20beta-diol

45. Beta-d-glucopyranoside, (3beta,12beta)-12,20-dihydroxydammar-24-en-3-yl

46. .beta.-d-glucopyranoside, (3.beta.,12.beta.)-12,20-dihydroxydammar-24-en-3-yl

2.4 Create Date

2005-08-08

3 Chemical and Physical Properties

Molecular Formula	C₃₆H₆₂O₈
Molecular Weight	622.9 g/mol
XLogP3	5.6
Hydrogen Bond Donor Count	6
Hydrogen Bond Acceptor Count	8
Rotatable Bond Count	7
Exact Mass	622.44446893 g/mol
Monoisotopic Mass	622.44446893 g/mol
Topological Polar Surface Area	140 Å²
Heavy Atom Count	44
Formal Charge	0
Complexity	1070
Isotope Atom Count	0
Defined Atom Stereocenter Count	15
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1